The clearance allows human trials for its one-time treatment targeting a genetic eye disease that causes vision loss.

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

Dr. Linda Genen named CMO to further strengthen GeneDx’s commitment to delivering earlier answers and better outcomes through ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

Researchers have unlocked the final gaps in the human genome, and what they tell us could mean big waves for the future of ...

CHANGE-seq-BE was developed to enable scientists to better understand base editors, an important class of CRISPR precise genome editors.

January 5, 2026) Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the ...

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE-1 in shaping the cancer genome structure and regulation.

A Viewpoint published in Genomic Psychiatry by Dr. Mayana Zatz and colleagues at the Human Genome and Stem Cell Research ...

Angiosperms, also known as flowering plants, represent the most diverse group of seed plants, and their origin and evolution ...